PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma-Reference-Cited by-同舟云学术

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma

Published:2017-06-01 Issue:6 Volume:135 Page:541
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Gezgin Gülçin¹,Luk Sietse J.²,Cao Jinfeng³,Dogrusöz Mehmet¹,van der Steen Dirk M.²,Hagedoorn Renate S.²,Krijgsman Daniëlle¹,van der Velden Pieter A.¹,Field Matthew G.⁴,Luyten Gregorius P. M.¹,Szuhai Karoly⁵,Harbour J. William⁴,Jordanova Ekaterina S.⁶,Heemskerk Mirjam H. M.²,Jager Martine J.¹

Affiliation:

1. Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands

2. Department of Haematology, Leiden University Medical Center, Leiden, the Netherlands

3. Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands3Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China

4. Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida

5. Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands

6. Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands7Center for Gynecological Oncology Amsterdam, Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular Melanocytic Tumors;Ocular Pathology;2025

2. PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation;2024-07-26

3. PRAME Expression in Merkel Cell Carcinoma;American Journal of Surgical Pathology;2024-07-12

4. Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non‐acral nevus‐associated melanoma in situ: An institutional experience and meta‐analysis;Journal of Cutaneous Pathology;2024-06-21

5. Performance of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry for metastatic melanoma in cytology specimens;Diagnostic Cytopathology;2024-04